AltraTech
Founded 2013 · 139 employees on LinkedIn · 1 known investors
Altratech has developed a multianalyte molecular diagnostic platform that simultaneously detects and quantifies DNA, RNA, antibodies, and antigens, combining serology and nucleic acid detection in one system. The technology is aimed at point-of-care molecular diagnostics.
Investors · 1
Frequently asked questions
- What does AltraTech do?
- Altratech has developed a multianalyte molecular diagnostic platform that simultaneously detects and quantifies DNA, RNA, antibodies, and antigens, combining serology and nucleic acid detection in one system. The technology is aimed at point-of-care molecular diagnostics.
- Who are AltraTech's investors?
- AltraTech's investors include Kernel Capital.